Clearmind Medicine signs research deal to study MEAI with tirzepatide

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/30/2026

1. CMCSA
2. LFTO
3. QNT
4. NVDA
5. VRDN
6. INIO
7. HONA
8. ABBV
9. HON
10. SPY

Go back to Clearmind Medicine signs research deal to study MEAI with tirzepatide
(NASDAQ: CMND) Delayed: 2.30 -0.08 (3.36%)
Previous Close $2.38    52 Week High $ 
Open $2.35    52 Week Low $ 
Day High $2.42    P/E N/A 
Day Low $2.04    EPS $ 
Volume 4,918,652